These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37275515)

  • 1. Aspirin as a thromboprophylaxis agent after revision knee arthroplasty: A retrospective analysis.
    Abourisha E; Srinivasan A; Bishnoi A; Rudge S; Best A; Chatterji U
    J Orthop; 2023 Jul; 41():23-27. PubMed ID: 37275515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
    Hovik O; Amlie EJ; Jenssen KK
    J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis.
    Coveney EI; Hutton C; Patel N; Whitehouse SL; Howell JR; Wilson MJ; Hubble MJ; Charity J; Kassam AM
    Cureus; 2023 Mar; 15(3):e36464. PubMed ID: 37090282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous Thromboembolism in Total Hip and Total Knee Arthroplasty.
    Simon SJ; Patell R; Zwicker JI; Kazi DS; Hollenbeck BL
    JAMA Netw Open; 2023 Dec; 6(12):e2345883. PubMed ID: 38039005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
    Ghosh A; Best AJ; Rudge SJ; Chatterji U
    J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
    Forster R; Stewart M
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.
    Baumgartner C; Maselli J; Auerbach AD; Fang MC
    J Gen Intern Med; 2019 Oct; 34(10):2038-2046. PubMed ID: 31236894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.
    Sidhu VS; Graves SE; Buchbinder R; Naylor JM; Pratt NL; de Steiger RS; Chong BH; Ackerman IN; Adie S; Harris A; Hansen A; Cripps M; Lorimer M; Webb S; Clavisi O; Griffith EC; Anandan D; O'Donohue G; Kelly TL; Harris IA
    BMJ Open; 2019 Nov; 9(11):e031657. PubMed ID: 31699735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty.
    Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
    J Arthroplasty; 2018 Jul; 33(7S):S131-S135. PubMed ID: 29656974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
    ; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
    JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
    Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
    J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Analysis Comparing Post-Operative Bleeding with Various Doses of Aspirin after Lower Extremity Joint Arthroplasty or Revision.
    Watts PJ; Kopstein M; Harkness W; Cornett B; Dziadkowiec O; Jenkins P; Hicks ME; Hassan S; Scherbak D
    Pharmacotherapy; 2021 Jul; 41(7):616-622. PubMed ID: 34050970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
    Arsoy D; Giori NJ; Woolson ST
    Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
    Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
    Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal thromboprophylaxis in low-risk patients undergoing lower limb arthroplasty: A retrospective observational cohort analysis of 1400 patients with ultrasound screening.
    Harrison-Brown M; Scholes C; Douglas SL; Farah SB; Kerr D; Kohan L
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020926790. PubMed ID: 32484038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel venous thromboembolic disease (VTED) prophylaxis for total knee arthroplasty-aspirin and fish oil.
    Bonutti PM; Sodhi N; Patel YH; Sultan AA; Khlopas A; Chughtai M; Kolisek FR; Williams N; Mont MA
    Ann Transl Med; 2017 Dec; 5(Suppl 3):S30. PubMed ID: 29299477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thirty Days of Aspirin for Venous Thromboembolism Prophylaxis Is Adequate Following Total Knee Arthroplasty, Regardless of the Dose Used.
    Shohat N; Ludwick L; Goel R; Ledesma J; Streicher S; Parvizi J
    J Arthroplasty; 2021 Sep; 36(9):3300-3304. PubMed ID: 34052098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty day low-dose versus regular-dose aspirin for venous thromboembolism prophylaxis in primary total joint arthroplasty.
    Duke AJ; Bowen S; Baig S; Cohen D; Komatsu DE; Nicholson J
    J Orthop Surg (Hong Kong); 2023; 31(2):10225536231173329. PubMed ID: 37137821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision.
    Watts PJ; Kopstein M; Harkness W; Cornett B; Dziadkowiec O; Hicks ME; Hassan S; Scherbak D
    Pharmacotherapy; 2021 Jul; 41(7):608-615. PubMed ID: 34050956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.